Biofrontera AG (ETR:B8FK)
3.080
-0.040 (-1.28%)
Oct 26, 2026, 5:43 PM CET
Biofrontera AG Revenue
Biofrontera AG had revenue of 5.32M EUR in the quarter ending June 30, 2026, with 78.18% growth. This brings the company's total for the last twelve months to 15.97M, up 42.05% year-over-year. In the year 2025, Biofrontera AG had annual revenue of 13.19M with 8.26% growth. That makes Biofrontera AG the 34,453rd largest company in the world by revenue and 485th in Germany.
Revenue (ttm)
15.97M
Revenue Growth
+42.05%
P/S Ratio
1.19
Revenue / Employee
257.50K
Employees
69
Market Cap
18.72M
Revenue by Geography
- Germany 9.86M 74.8%
- Spain 1.73M 13.1%
- UK 978.00K 7.4%
- Rest of Europe 609.00K 4.6%
- Other Regions 14.00K 0.1%
Fiscal year ended Dec 31, 2025 See the full Biofrontera AG breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.19M | 1.01M | 8.26% |
| Dec 31, 2024 | 12.18M | -20.06M | -62.22% |
| Dec 31, 2023 | 32.25M | 6.51M | 25.29% |
| Dec 31, 2022 | 25.74M | -3.05M | -10.59% |
| Dec 31, 2021 | 28.79M | -1.56M | -5.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.38B |
| Fresenius SE & Co. KGaA | 23.28B |
| Siemens Healthineers AG | 23.17B |
| Merck KGaA | 21.14B |
| Maternus-Kliniken Aktiengesellschaft | 119.35M |
| FamiCord AG | 87.78M |
| MeVis Medical Solutions AG | 15.48M |
| Geratherm Medical AG | 13.97M |